EMA Approves Pfizer Vaccine for Children 5-11 Years

The European Medicines Agency (EMA) issued on Thursday the recommendation to expand the use of the vaccine Pfizer / BioNTech against coronavirus, Comirnaty, in children between five and 11 years old.

“The EMA Committee for Medicinal Products for Human Use has recommended extending the indication for the vaccine Comirnaty against the covid-19, including use in children from five to 11 years of age, “the statement said.

It should be noted that the dose for this group will be even lower than the dose for adolescents from 12 years of age, for whom the drug has been authorized since the end of last May.

According to the EMA, in a study involving 2,000 children between the ages of five and 11, Comirnaty demonstrated an efficacy of more than 90 percent.

In mid-October, the European regulator began to study the request of the companies Pfizer and BioNTech to extend the use of their vaccine to minors from five years of age. The evaluation was estimated to take a couple of months.

To date in the EU, four vaccines against him coronavirus: Pfizer / BioNTech, AstraZeneca, Johnson & Johnson and Moderna. The latter, along with Pfizer / BioNTech, is also applied to immunize adolescents from 12 years of age.

Source: Sputnik

Coronavirus“target =” _ blank “> Coronavirus today in the world: all the information

Coronavirus in Argentina: All the information about the pandemic throughout the country

Coronavirus vaccine: progress in the race to combat covid-19

Leave a Comment